DaVita announces Q1 2026 financial results
Revenues reached $3.416 billion, operating income $482 million, and diluted EPS $2.87. The company repurchased 3 million shares.
See the latest news and media coverage for DaVita. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of kidney care and dialysis services
davita.comLast updated
In short: DaVita raised its annual profit forecast after beating Q1 earnings expectations, driven by strong dialysis demand and operational technology use.
Revenues reached $3.416 billion, operating income $482 million, and diluted EPS $2.87. The company repurchased 3 million shares.
The initiative promotes integrated cardiovascular, kidney, and metabolic care using evidence-based tools across 150 sites to improve outcomes and reduce costs. DaVita invests in AI and multidisciplinary teams.
The recognition honors the team's dedication to advancing kidney care and innovative healthcare solutions.
CKCC results show 9% quality score improvement, $200M shared savings, and better patient outcomes like optimal starts and lower CVC use.
Free US stock macro sensitivity analysis and sector exposure assessment for economic condition positioning and scenario planning. We help you understand which types of stocks...
On May 15, 2026, DaVita Inc DVA shares rose 3.7% to a current price of $199.74, reflecting a significant increase of 38.2% over the past...
Shares of DaVita Inc. DVA rallied 3.72% to $199.74 Friday, on what proved to be an all-around poor trading session for the stock market, with...
DaVita's first quarter results were met with a strongly positive market reaction, reflecting operational execution and ongoing cost control. Management attributed the quarter's outperformance to...
Track DaVita and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to DaVita and other trending companies.